ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000576.1|Rubrivinodin_1 # 1 # 2790 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.757	BGC0000576.1|Rubrivinodin_1 	1	2790	+	Loose	500	28.1054	TEM-111	40.0	3000974	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	GTGGGCGGCCGCAGCGCGCGGCCGGTGTCGGGCCGGCTGTCGGCCGCCGAGGCCGTGGCGCTGGCGTTGGAAGGCTCGGGCCTGGTGGCCGAGGTGATGGCCGACGGCGCCATCGTCGTGCGGCTGGCGCCGCCACCGGCGGCGGCCTCGGGCCTGGCGCCGCGCAGCACCCACGCGCTGCTGACGGTGGCCGACGCGTCGGTGCCGGCCGCGTGGCCGGTGGCGGGTGAGGCCGCGGCCGACGAAGCGGGCGCGCGCGCAGCGGCCGGGGCCGATGGTGCGCAGAAGATCCAGATCACCGGCTCGCGCCTCAAGCGCATCGCGGCCGAAGGGCCGGCGCCGGTGAACGTCTACACGAAGGAGGACATCGAGCGCAGCGGCCAGCCGACGCTGGAGCGCTTTCTGGCCGGGCTGAACGAGGCCTCGGTGGCGCCGGGCGAAGGCGCGCAGGGGGCGACCACGGGGCAGGGCGCGGTGCAACTGCGCGGGCTGCCGCTGGGCTCGACGCTGGTGCTGATCAACGGGCGGCGCGCGCAGGCGGTGGGCTCGTCGTCGGCCAACTTCTTCAACCTCAGCCTGATCCCGCTGGCCGCGGTGGAGCGCGTGGAGGTGCTGCCGGTGGGCTCGTCGGCGGTGTACGGCGGCGACGCGCTGGCCGGCGTGGTGAACGTGATCCTGAAGAAGTCGATCGATGGCCTGTCGCTGGCCGCGCGGGCCGGCGCCGGCCAGGGCAGCAGCGACAGCAGCCTGTCGCTGGCGGCGGGCGGGCAGACGGAGCGTGCCTCTTATCTGCTGCTGGGTTCGTACAGCCGCAATACGCCGCTGACGATGGCCGAGCGCGGCTTCTTCCGCAGCGGCGACTACCGGCGCGACGGCGGCCCCGACACGCGCACGCGCGGCTGCACGCCGGGCACGGTGTCCAGCACGACCGGCGCGGCACTGCCCGGGCTGGGTTCGCCGGTGGCCGGCATCCCGCGCGTGCCGGCGGGGCAGCCACTGGTGCCGGGCGACTTCGCCGCGCTGGACGGGCAGCCCAACCTGTGCAACAGCCTGGCCAACGGCCACGGCTACGCGCTGGTGCATGGCGACGAGACCTGGGGCCTGCATGCGGTGGGCGAGTGGCGGCTGGGCGAGACCTGGGCCGCCTTCGGCGAGCTGACCCACACCCGCGACACGCTGCGCGCCGAGCAGACCGGCCTGGCGCTGAACAACGTGCTGGTGCCGGCCGGCAGCCCGTACAACCCCTTCGGCGAGGCGGTGCGCGTGACGGGCCGCCTGGGCCTGGACAACGGCGCCGAAGGCCTGGCGCGCGACACGCGTTTCACCCGTGCGCTGCTGGGCCTGCGTGGCGAGCTGGCCGCCGGCTGGGACCTGGAAGCCACGCTGTCGACCTCGCGCGACGACGGCGAGCGCCGCCTGCTGAACGGCAGCGTGAACGCCGCCGCGCTGGCAGCGGCCCTGGGCGCGACGACGCCCGACGCCGCGCTGAACCCCTTCACCACCGGCCCGGCTGCCAGTGCCGACGTGCTGCGCGGCATCTGGCAGGACAGCGTGCGCCAGAACCACGGTCGCAAGGACATGGCGGCAGCCTTCGTGCGCGGGCCGCTGGCCCAGCTGCCGGCCGGGCCGGTGGAGGCGCTGGCGGGCGTGGAGGCCGCACGCGACTGGTACGAGACCACGCTGTCGGGCGTGACCACCCGGGACAGCCGCAACGCCGCCGCCGTGTACGGCGAACTGCGCCTGCCGCTGCTGCGCGCCGGCGCCGAAGAAGGCCGCGGCTGGCCGCTGACGACGCTGACGCTGGCCGGCCGCCGCGACCGCTACAGCGACTTCGGCAGCGCCGGCACCTACCAGGCCGGCGTGGAGCTGCGGCCTGCGCGCAGCGTGCTGCTGCGGGCGTCGACGGCCACCTCCTTCAAGCCGCCGACGCTGCTGCAGACCAGCGTCGACGACACCAGCATCCCGGCCGAAGCCTTCGGCCTGGTGGACCCGGCGCGTGGCGGCGAGGCGATCACCGGCGCCGAGGTGCTGCGCACGTCCAACCCCGACCTGGGCCCCGAGAAGGGCCGGGCCTGGTCGCTGGGCGCGGTGTGGGAGCCCGACGGCAGCCTGGGAACCCGGCTGGCGGTGACGGCCTGGCGCGTGTCGATCGACGGCCTGATCGCGCTGCTGTGGCCGCAGGTGACGCTGGACTACGAGAGCCGCTTTCCCGGGCTGGTGACGCGCGGGCCCTCGGTCGGCGGCCAGCCGGGTGCGGTGACGCAGGTGCTGTACTCCGAAGTGAACTTCGGCCGCCTGGACACCGCCGGCGTCGACCTGGATGCGGCCTACGCCTGGCGTGCCGCCGGGGCCCGCTGGACGCTGGCCGGCAGCGCCACCCGCACCAGCCGCTACGACGTGGCCGTGGCACCCGGTGCGGCGGCCGAAGACCGCGTGAGCCGGCGCGCGCTGGACTACTGGGCCCCGCGCTGGAAGGGCCGGCTGTCCGCCGGGCTGGACACCGGCACCTGGGGCCTGGGGCTGACCGGGCGCTACCTGGGCAGCTACCGCGACACCGCCGGCGACGGCCGCCGCCTGGGCGACGACTGGCAGTTCGATCTGGCCGGCCGGGTGGACCTCAAGCGTCTCGGCTGGGCGCCGGCCAGCGCGAAAGCGGCATCGCTGGGGCTGGCCGTCACCAACCTGGGCGACCGGCAGCCCGAGTTCGTCGCCGCGGCGCCGTACTACGACGTCACCCAGGCCGACTGGCGCGGGCGCTACGCCAGCCTGCGGCTGTCGGTCGACTGGTAA	VGGRSARPVSGRLSAAEAVALALEGSGLVAEVMADGAIVVRLAPPPAAASGLAPRSTHALLTVADASVPAAWPVAGEAAADEAGARAAAGADGAQKIQITGSRLKRIAAEGPAPVNVYTKEDIERSGQPTLERFLAGLNEASVAPGEGAQGATTGQGAVQLRGLPLGSTLVLINGRRAQAVGSSSANFFNLSLIPLAAVERVEVLPVGSSAVYGGDALAGVVNVILKKSIDGLSLAARAGAGQGSSDSSLSLAAGGQTERASYLLLGSYSRNTPLTMAERGFFRSGDYRRDGGPDTRTRGCTPGTVSSTTGAALPGLGSPVAGIPRVPAGQPLVPGDFAALDGQPNLCNSLANGHGYALVHGDETWGLHAVGEWRLGETWAAFGELTHTRDTLRAEQTGLALNNVLVPAGSPYNPFGEAVRVTGRLGLDNGAEGLARDTRFTRALLGLRGELAAGWDLEATLSTSRDDGERRLLNGSVNAAALAAALGATTPDAALNPFTTGPAASADVLRGIWQDSVRQNHGRKDMAAAFVRGPLAQLPAGPVEALAGVEAARDWYETTLSGVTTRDSRNAAAVYGELRLPLLRAGAEEGRGWPLTTLTLAGRRDRYSDFGSAGTYQAGVELRPARSVLLRASTATSFKPPTLLQTSVDDTSIPAEAFGLVDPARGGEAITGAEVLRTSNPDLGPEKGRAWSLGAVWEPDGSLGTRLAVTAWRVSIDGLIALLWPQVTLDYESRFPGLVTRGPSVGGQPGAVTQVLYSEVNFGRLDTAGVDLDAAYAWRAAGARWTLAGSATRTSRYDVAVAPGAAAEDRVSRRALDYWAPRWKGRLSAGLDTGTWGLGLTGRYLGSYRDTAGDGRRLGDDWQFDLAGRVDLKRLGWAPASAKAASLGLAVTNLGDRQPEFVAAAPYYDVTQADWRGRYASLRLSVDW	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGADERGSRGIIAALGPDGKPSRIVVIYMTGSQATMDERNRQIAEIGASLIKHW	324.83	gnl|BL_ORD_ID|1824|hsp_num:0	1973			660	795	ampicillin
BGC0000576.1|Rubrivinodin_2 # 2858 # 5242 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=3-4bp;gc_cont=0.743	BGC0000576.1|Rubrivinodin_2 	2858	5242	+	Loose	275	25.7942	AAC(6')-Il	30.63	3004635	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTCCCGTTCTTCCCCGGGGCGTCGCCTGCGTGCGGCGTCCCGTCGTCTGCTGCGTCTGCTGGCGCCTTTCGTCCTGCCGGTGCTCGTGTCGGCCCCCGCCCGCGCCGAGGGCTACGCGGGCGGCCCGACGGTGCAGGACGTCGTCGAGTTCACGCGCATCGTGCAGCCCTTCAACCACGACGCCGACACGCTGCGGCAGCAGGTCTCGCCCGACGGCCGCCAGGCCTTCATCGTGACGCGCCGGGCCCTGGTGGCGCGCGACGTGAACCGCTTCGAGATCCTGCTGCTGGACGTGGCGCCCGAGCGGCTGGCCGCGGCGGGGCGCGACGCGCGCCGCGACCCGCCGCGCGCGGCCTGGGTGCTGGACGCCCACGACGACGGCGACGACGCCGACCCGCCGCTGCAGGACGTGCGCTGGGCCGGCAACCGCACGTTGGTCTTCCGCGCCCGCGTTCAGGGGCAGCCGTTCCAGGCTTACGCGCTGGACGTCGGCACGCGGCGGCTGCAGCAGCTGACGTACGACGCCGACGGCGTGGCGAGCTTCGACCTGTCGGCCGACCGGCGGCGCGTGGTCTACCTGGCGCCGGTACCCACCCCGCCGCTGAAGCCCGGCGCGCACGGTGTTGTGGTCGGCAACCAGTCGTTCTGGAGCGTGATGTTCGGCCAGCACGACCGGCGTGCGCAGCAGCGGCGCTACCAGTACCGGCTGGCCGACGGCGGCGGGCCCGGGCGCGCGCTGGGCGAGCCCTTCGCCGAAAGCAGCAGCCGATATCCGCGGCCCAGCGTGTCGCCCGACGGCCGCTGGGCGCTGCTGCCGCGCTACGACGCCGAGCGCCAGCCGACCTGGGCGCTGCGCTACCCGCTGGTGGCCGACGCCGCTGCGCGCTACGGTGCCGGTGCGTTGCAGGACCCGCTGCAGTACTACTCGCGCCCGTACTCCTACGTCGCGCGACGGCTGGTGGCGGTGCGCCTGGACAACGGGCGCGAGCAGGCGGTGTTCGACGCGCCCGACGACACGCTCCCCGGCCTGAGCCAGCTGCGGCCCGACCGGCTGTGGCGTGCCGACGGTGCTTCTGTGGTGATCGCCGGCACGAACCTGCCGCCGCCGGCCGACGGCCAGCCGGCGAGCCCGGCACCGCACGTCGTCGAGTACTGGCCCGACTCGGGGCGCTGGCACGCGTTTGCCGAGCTGAAGAGCCGGCTGGTGGCGGCCTGGCCGGTGGCGGGCCGCAGCGACGTGGTCGAGCTGCTCGACGGCGCCACACGGCGGCGCTTCGCGCGCTCGCCGGACGGGCGCTGGCGCGAGCTGGACGCCGCGGCCGAAGCGGCGAGCGGCTGGACGCTGCGCATCGACGAGGCCTTGAACCAGCCGCCCGACGTCGTGGCCGTGGCGCCCGACGGCCGCACGGTGCGCCTGACCGAGCTGAACCCGCGTTACCAGCCGGTCGTGTGGGGCACGATGCGCCCGTACGCCTGGCGCGACACGAAGGGCCGGCCCTGGCAGGGCGGGCTGATGACGCCGGCCGGCCACGAACGCGGTGCGCGCCACGCGCTGGTCATCCAGACCTACGGCTTCTCGCCCGAGCGCTTCTACCTCGACGGGCCCAACCAGTTCAGCGGCTACACCAGCGGCTTCGCAGGGCGTGCCTTCCTGCGTGAGGGCCTGCTGGTGCTGGCGATGCCGTGGGCAGCGTCCAGCGGCGCGCCCGACAACGAGCACGAAGGCATCGCTGCCTTCGCCGACGGCGTGGCCGGCGCGGTGGAGCAGCTGGTGGCCGAAGGGCTGGTGGACCGCGAGCGCGTCGGCATCATCGGCTGGAGCGCGACCGGCGAACGCGTGCTGAACCTGCTGACCTTCTCCGACGCCCCGATGCGCGCGGCCAGCATCCTGGACGGCGACGCCAACACGCTGTTCTCGCTGACGGTGACCTACGCGGTGAAGGACGGCATCCTGCGCCGCAAGGAGCAGGCGAACCAGGGCGGCCCGTTCGGCGAGGCGCTGCAGCGCTGGGTGCGCAACGACCCGTCGCTGCACACCGACTGCATGCGCGCGGCGCTGCGCATCGAGAGCTACGGCCCGCTGGTGCAGAACAACTGGGACATCTACGCGCTGCTGCGCCGCCAGTACAAGCCGGCCGAGATGATCGTCATCCCCGGCGGCGCCCACGCGCTGTCGCGCCCGGCCGAACGCCTGCTGTCGCTGCAGGGGAACGTCGACTGGTTCCGCTTCTGGCTGCTGGGCGGCGAGCGCCAGGCCCCCGTGCTGCCCGGCGAGACGGCCGCCGACCTGCAGGCGCAGTACACGCGCTGGCGGCAGATGGCGGACCTCAAGCGAGCGGACGAGGCGCGGCCGCGGTGTGAGCGGGAGGGTGCTGGCGGTTAG	MSRSSPGRRLRAASRRLLRLLAPFVLPVLVSAPARAEGYAGGPTVQDVVEFTRIVQPFNHDADTLRQQVSPDGRQAFIVTRRALVARDVNRFEILLLDVAPERLAAAGRDARRDPPRAAWVLDAHDDGDDADPPLQDVRWAGNRTLVFRARVQGQPFQAYALDVGTRRLQQLTYDADGVASFDLSADRRRVVYLAPVPTPPLKPGAHGVVVGNQSFWSVMFGQHDRRAQQRRYQYRLADGGGPGRALGEPFAESSSRYPRPSVSPDGRWALLPRYDAERQPTWALRYPLVADAAARYGAGALQDPLQYYSRPYSYVARRLVAVRLDNGREQAVFDAPDDTLPGLSQLRPDRLWRADGASVVIAGTNLPPPADGQPASPAPHVVEYWPDSGRWHAFAELKSRLVAAWPVAGRSDVVELLDGATRRRFARSPDGRWRELDAAAEAASGWTLRIDEALNQPPDVVAVAPDGRTVRLTELNPRYQPVVWGTMRPYAWRDTKGRPWQGGLMTPAGHERGARHALVIQTYGFSPERFYLDGPNQFSGYTSGFAGRAFLREGLLVLAMPWAASSGAPDNEHEGIAAFADGVAGAVEQLVAEGLVDRERVGIIGWSATGERVLNLLTFSDAPMRAASILDGDANTLFSLTVTYAVKDGILRRKEQANQGGPFGEALQRWVRNDPSLHTDCMRAALRIESYGPLVQNNWDIYALLRRQYKPAEMIVIPGGAHALSRPAERLLSLQGNVDWFRFWLLGGERQAPVLPGETAADLQAQYTRWRQMADLKRADEARPRCEREGAGG	MDSSPLVRPVETTDSASWLSMRCELWPDGTCQEHQSEIAEFLSGKVARPAAVLIAVAPDGEALGFAELSIRPYAEECYSGNVAFLEGWYVVPSARRQGVGVALVKAAEHWARGRGCTEFASDTQLTNSASTSAHLAAGFTEVAQVRCFRKPL	522.37	gnl|BL_ORD_ID|2117|hsp_num:0	3334			27	312	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000576.1|Rubrivinodin_3 # 5187 # 7040 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000576.1|Rubrivinodin_3 	5187	7040	-	Loose	450	28.4906	SSA	34.21	3007442	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	SSA beta-lactamase	ATGTTCCGGTACGTCGCATTCGTCTGGGACGCCACCTGCCCGCCGCGGGTCGATGCGGCAGCACGACTCGCCCAGTCGCTTGCGCCGCATTGGCAGGCGGCGCACAGGCAACCCGGCCTGCAGGTCCATGTGACGGGTTCGCCCCCCGGGCACACGCGCGTGCACCTGCTGCGCGAACGACGGGGCGTCGTCATCGGCACGCTCTTCCGCCGCGACGATGGCGGTGGAGCGCCGCTGCCGTCCAGCGGACTGGACGCCGCCGAGTCGGACCGCATCGCGCATGGCGGTGGCCGCGCACTGGTGCAGGACTTCTGGGGACGCTACGTCGCTTTCCTCTGCACCGAAGGCGGACGCACGCGCCTGCTGCGCGACCCCAGCGGCGCCCTGCCCTGCTACCTGCTGCGGCATGAAGGGGTGTGGATCGTCTGCTCCTGGCTCGAAGACGCGCTGGCGCTGCTTCCCGCCACCGTCGGCTTCGCCGTGAACTGGCCCGCCGTCGCTGCGCAACTGCTGATCGGCGAACCCGGTGGACGAGACACCGCCTTGTTCGGCGTGCAACAGGTCGCACCGGGCGAGGCCATCGATCTCGCCCACACGGCAAGCGCAGGCGAGTTGCTCTGGGATGCCACCTCGTTCGCCAGGCAGCCGCTCACGCACGGCCCGGACATGGCCGTCATCGCGCTGCGCGAAACAGTGCAGGCCTGCGCCAGCGCCTGGGCAGGGTGCCACGACCGGGTGCTGTTCCGCCTGTCCGGCGGCGTCGACTCATCGATCCTGCTGAGCTGCCTGTCGCGGGGGCGGACGCACACCCACGTGACCTGCGTGAACTACCACTCGGCCGGCGCCGATGGCGACGAACGCCGCTATGCGCGCCTGGCCGCCAACAGCGCCGGCTTTCCGCTGGTCGAACGCGAGCGCAACACGGACTTCCGACTTCAAGACCTGCTGACGATCGCACGCACGCCGACACCGGGCAACTACGTCGGGAGACTGAGCGCTCGTGCCGATGCCGAACTGGCCGCTGAATACGGCAGCGGCGCACTGTTCACCGGCGCTGGCGGCGACCAGCTGTTCTTCGAGTTCGGCCGTCCCTGGCCCGCCGCCGACTACCTGCACTGCCGCGGCCTGGACTTCGGTTTCCCGGCGGCAGCCATGGACGCCGCGCGGCTGGGCCGCGTGTCGGTGTGGAGCGCGATGGCCTACGCCTTCAGGCAGCGGCTGCGGCCGACCAGACTCCTGGACGATCCCCGGCCGCCACTGCTGGGCCCGGCGGTCCCGGACGACCGCACGCGGCTGCAGCAGTTCCTGCATCCCGCGCTGCGCGACGGCAGAGTGCTGCCCATCGGCAAACAGGTCCAGACACGTGCCTTGCTGCACCCCGCACCGTTCTATGACCCCTTCCAGCGCCAGGCAGCACCGGAGCTCGTCAACCCGCTGCTGTCGCAGCCCTTGATCGAACTCTGTCTTCGCCTGCCGACCTGGGTGCTGACACATGGCGGCCGCGGCCGGGCCCTGGCGCGGCGCGCCTTCGCCGACGAACTGCCGCCCGAGATCCGCACCCGCCGCGCCAAGGGCGGCATGGAAGAGCTTCTGCAAGCCGTGTTGCTGCGCAACCTCGGCTTCGCGAAAGAGCTGCTGCTCGACGGCGAACTCGCGCGGCGCGGGCTGCTCGACCGTGCGCGGCTCGAACAAGCCTTGTCGGACCGGCCCACCACGCTCGCCGCGCACGTGAGCCAGCTCCACGTCTACCTGGGCATCGAGGCCTGGCTGGCGCAATGGACGTCGGCTTCGCCATGCGCTAACCGCCAGCACCCTCCCGCTCACACCGCGGCCGCGCCTCGTCCGCTCGCTTGA	MFRYVAFVWDATCPPRVDAAARLAQSLAPHWQAAHRQPGLQVHVTGSPPGHTRVHLLRERRGVVIGTLFRRDDGGGAPLPSSGLDAAESDRIAHGGGRALVQDFWGRYVAFLCTEGGRTRLLRDPSGALPCYLLRHEGVWIVCSWLEDALALLPATVGFAVNWPAVAAQLLIGEPGGRDTALFGVQQVAPGEAIDLAHTASAGELLWDATSFARQPLTHGPDMAVIALRETVQACASAWAGCHDRVLFRLSGGVDSSILLSCLSRGRTHTHVTCVNYHSAGADGDERRYARLAANSAGFPLVERERNTDFRLQDLLTIARTPTPGNYVGRLSARADAELAAEYGSGALFTGAGGDQLFFEFGRPWPAADYLHCRGLDFGFPAAAMDAARLGRVSVWSAMAYAFRQRLRPTRLLDDPRPPLLGPAVPDDRTRLQQFLHPALRDGRVLPIGKQVQTRALLHPAPFYDPFQRQAAPELVNPLLSQPLIELCLRLPTWVLTHGGRGRALARRAFADELPPEIRTRRAKGGMEELLQAVLLRNLGFAKELLLDGELARRGLLDRARLEQALSDRPTTLAAHVSQLHVYLGIEAWLAQWTSASPCANRQHPPAHTAAAPRPLA	MKRIFPAYILLTAFLLACSSNATTQNANQSNKPAAAQEAKADDKQNRELQKQIEQIASAARGRVGVHAVVLETGESVSLDEQGRFPMQSVYKFPIGMAVLAQVDAGKLKLDERVRVEKSEYVREGMHSPLRDKNPNEAEVSVRELLRLAVSESDGTASDVLFRLAGGSEAITRYLSDLKVTEIIVADTEKEIGQDWDTQYRNWASPKGAVMLLRAFHEGRGLSAESRALLLKLMTDTPTGPKRLKGLLPKGTVVAHKTGTSGANASGISAATNDIGIVTLPNGRHLAIAVFVSDSPADLTTREGVIAKVAKAAWDQWGK	193.42	gnl|BL_ORD_ID|4942|hsp_num:0	5934			396	510	cefoxitin; ceftazidime; amoxicillin; ampicillin
BGC0000576.1|Rubrivinodin_4 # 7053 # 7778 # -1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.700	BGC0000576.1|Rubrivinodin_4 	7053	7778	-	Loose	930	26.1794	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide	28.17	3004721	protein variant model	D123A	n/a	pyrazine antibiotic	antibiotic target alteration	pyrazinamide resistant rpsA	TTGATTCAGCCCGCGCCAACCTCGCCCCGCGCACTGTCCCTGGCGCCGCATGTCCGCGCCTGTGCGACCGGCGGCCAAGTCATCCTGCTGGACCTGCGCAGCGGCACCTACCTCGGCCTTGCGGGCGACCGTCTCGCCGCTCTCGCCGGAGGGGTCGCGGGATGGCCGAACCCGACGCGGAAGGAAGGCGAGACGGCACCGACCTCGATCGCCATCTACTCACTGGTTCGGCCGCTGCTGGCCCGCGGCCTGCTCGTGGAGCATCTCGTCGAGCCAGCCCCGATCGTCGAGCTGGAGGAACCTCGCTCGGCGCTCGACACGGACGACGCGATCGTCAGCGTGCGCACCAAGGACGTTGGCCGCTTCATCCACGCCGCCGGATCGGCCTCGGCCTGGCTACGGTGGCACTCGCTGCTCTGGATCGTCGAGGCCGCGACCGCACGCAGGGGAACGAACGCGAAGGCTCTCTGTGACTTCGAAGCACTGCGCCATGCGGTCGCCCGCTACGACAAGCTCCGGCCTCTGGCGTTCGCGGCGCAGGACCGATGCCTTTACGACTCGCTGGCGCTGCTGCTCTTCCTCGCCAGCGAGGGTCACTGCCCGCGCTGGGTCGTCGGCGTGCGCACGCGGCCGTTCGCCGCGCACTCCTGGGTCCAGAGCGGTTCGCTGGTGCTGAACGACCAGGCCGAACACGTGCGCGCGTTCAGTCCGATCCTCGTGGTCTAG	MIQPAPTSPRALSLAPHVRACATGGQVILLDLRSGTYLGLAGDRLAALAGGVAGWPNPTRKEGETAPTSIAIYSLVRPLLARGLLVEHLVEPAPIVELEEPRSALDTDDAIVSVRTKDVGRFIHAAGSASAWLRWHSLLWIVEAATARRGTNAKALCDFEALRHAVARYDKLRPLAFAAQDRCLYDSLALLLFLASEGHCPRWVVGVRTRPFAAHSWVQSGSLVLNDQAEHVRAFSPILVV	MPSPTVTSPQVAVNDIGSSEDFLAAIDKTIKYFNDGDIVEGTIVKVDRDEVLLDIGYKTEGVIPARELSIKHDVDPNEVVSVGDEVEALVLTKEDKEGRLILSKKRAQYERAWGTIEALKEKDEAVKGTVIEVVKGGLILDIGLRGFLPASLVEMRRVRDLQPYIGKEIEAKIIELDKNRNNVVLSRRAWLEQTQSEVRSEFLNNLQKGTIRKGVVSSIVNFGAFVDLGGVDGLVHVSELSWKHIDHPSEVVQVGDEVTVEVLDVDMDRERVSLSLKATQEDPWRHFARTHAIGQIVPGKVTKLVPFGAFVRVEEGIEGLVHISELAERHVEVPDQVVAVGDDAMVKVIDIDLERRRISLSLKQANEDYTEEFDPAKYGMADSYDEQGNYIFPEGFDAETNEWLEGFEKQRAEWEARYAEAERRHKMHTAQMEKFAAAEAAGRGADDQSSASSAPSEKTAGGSLASDAQLAALREKLAGSA	50.10	gnl|BL_ORD_ID|4709|hsp_num:0	3403			192	387	pyrazinamide
BGC0000576.1|Rubrivinodin_5 # 7840 # 7956 # -1 # ID=1_5;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.624	BGC0000576.1|Rubrivinodin_5 	7840	7956	-	Loose	525	23.0978	EFM-1	58.82	3006884	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	EFM beta-lactamase	ATGGACGAAGAGCTGGAACTGGAGATCGTCGACCTGGGTGACGCCAAGGAACTGACGCAGGGCGCGCCGAGCCTGATCAACTCGGAAGACAACCCGGCCTTCCCGCAGCGCGTCTGA	MDEELELEIVDLGDAKELTQGAPSLINSEDNPAFPQRV	MSARCLPALTLPLALAACAPPIQTPDPLPPREIVTPQQWAQQCTDWDEWDKPAPPYRIHGSTYYVGTCGIAAILVAGDGGHILIDSGTEAGADVVLDNVGKLGFRPNEIASLLHSHEHFDHTGGHALVRRESGAHVVASPQAAPVLRTGEDDPADPQHGLHDAMEPVPVDVIVRDGETVRSESATLTAIATPGHTPGALSWAWQSCDEAGDCLSIVYADSLSPISRKGYRFGDHPEYLEGFRAGLEKLRAVDCDILLTPHPSASDMVTRAAAGSMVGGMSCVDYADAVEARLDARLVEEAGD	12.58	gnl|BL_ORD_ID|3529|hsp_num:0	4598			420	471	
